Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas A. Armer currently holds 130,878 shares of MAP Pharmaceuticals, Inc. (MAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas A. Armer has been a net seller of MAPP stock. They have purchased $0 and sold $4.5M worth of shares.
Thomas A. Armer's most recent insider trade was on Jan 25, 2015, when they sold 1,034 shares at $24.75 per share.
Thomas A. Armer serves as Executive at MAP Pharmaceuticals, Inc. (MAPP). They have executed 23 insider transactions totaling $4.5M over their tenure at the company.
Thomas A. Armer holds the position of Executive at MAP Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Thomas A. Armer has shown a selling trading pattern, with $0 in total purchases and $4.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas A. Armer was on Mar 1, 2013, when they sold $5.6M worth of MAPP shares. This transaction involved 222,676 shares at $25.00 per share.
Thomas A. Armer currently owns 130,878 shares of MAP Pharmaceuticals, Inc. (MAPP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas A. Armer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas A. Armer has 23 Form 4 filings on record as an insider at MAP Pharmaceuticals, Inc..
Set alerts for Thomas A. Armer and 40,000+ other insiders.